Innovation in Medicine

A new control switch could make RNA therapies easier to program

Specialist researcher holding microscope slide analyzing blood sample working at coronavirus vaccine development during virus examination in microbiology hospital laboratory. Biochemistry experiment

Using an RNA sensor, MIT engineers have designed a new way to trigger cells to turn on a synthetic gene. Their approach could make it possible to create targeted therapies for cancer and other diseases, by ensuring that synthetic genes are activated only in specific cells.

Stimulus-sensitive polymeric micelles show promise for future targeted drug delivery and chemotherapy

Previous article

Your wallet will love these Apple Pencil deals

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *